Pathogenic relevance of autoantibodies in dilated cardiomyopathy
- 1 January 2010
- book chapter
- Published by Springer Nature
- p. 157-170
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the MyocardiumCirculation, 2006
- Removal of Pathogenic Autoantibodies by ImmunoadsorptionAnnals of the New York Academy of Sciences, 2005
- Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathyEuropean Heart Journal, 2004
- New insights into the pathogenesis of dilated cardiomyopathy: possible underlying autoimmune mechanisms and therapyAutoimmunity Reviews, 2004
- Familial clustering of autoimmune diseases in patients with dilated cardiomyopathyThe American Journal of Cardiology, 2004
- β1-Adrenoceptor autoimmunity in cardiomyopathyInternational Journal of Cardiology, 1996
- Structural basis of autoimmunity against G protein coupled membrane receptorsInternational Journal of Cardiology, 1996
- Autoimmunity in dilated cardiomyopathy and the major histocompatibility complexInternational Journal of Cardiology, 1996
- Dilated Cardiomyopathy Defines Serum Autoantibodies Against G-Protein-Coupled Cardiovascular ReceptorsAutoimmunity, 1995
- Assessment of immune modulation of β-adrenergic pathways in human dilated cardiomyopathy: Influence of methodologic factorsAmerican Heart Journal, 1992